Eosinophilic Esophagitis: Food Allergies and Esophageal Inflammation

Eosinophilic esophagitis (EoE) is a chronic, immune-mediated condition in which eosinophils — a type of white blood cell — accumulate in the esophagus and cause inflammation that interferes with swallowing and normal esophageal function. This page covers the diagnostic definition of EoE, its immunological mechanism, the food allergens most frequently implicated, and the clinical boundaries that distinguish it from other esophageal and allergic conditions. Understanding EoE is relevant for anyone navigating the overlap between food allergies and gastrointestinal disease.

Definition and scope

Eosinophilic esophagitis is defined by the presence of 15 or more eosinophils per high-power field (eos/hpf) on esophageal biopsy, combined with symptoms of esophageal dysfunction, after alternative causes — particularly gastroesophageal reflux disease (GERD) — have been excluded. This diagnostic threshold was established through consensus guidelines issued by the American College of Gastroenterology (ACG) and the American Academy of Allergy, Asthma & Immunology (AAAAI).

EoE affects an estimated 1 in 2,000 people in the United States (American Partnership for Eosinophilic Disorders, APFED). Prevalence has increased substantially since the condition was formally characterized in the early 1990s, though researchers attribute this partly to improved recognition and biopsy protocols rather than exclusively to rising incidence. The condition affects all age groups but is diagnosed more frequently in males, with a male-to-female ratio of approximately 3:1 (ACG Clinical Guideline, Dellon et al., 2022).

For broader context on how immune-mediated conditions are classified and regulated in clinical practice, the regulatory context for allergy provides relevant framing on diagnostic standards and oversight.

How it works

EoE is driven by a Th2-predominant immune response triggered primarily by food antigens, though aeroallergen sensitization has also been implicated in a subset of patients. The mechanism differs fundamentally from IgE-mediated food allergy:

  1. Antigen exposure — dietary proteins enter esophageal tissue and activate antigen-presenting cells.
  2. Th2 cytokine release — interleukins IL-4, IL-5, and IL-13 are secreted, promoting eosinophil recruitment and survival in esophageal tissue.
  3. Eosinophil accumulation — eosinophils infiltrate the squamous epithelium of the esophagus, releasing toxic granule proteins including major basic protein (MBP) and eosinophil-derived neurotoxin (EDN).
  4. Tissue remodeling — chronic inflammation leads to subepithelial fibrosis, esophageal rigidity, and stricture formation if untreated.
  5. Symptom expression — dysphagia (difficulty swallowing), food impaction, heartburn refractory to proton pump inhibitors (PPIs), and chest pain are primary presentations.

Because the underlying pathway is non-IgE-mediated, standard allergy skin-prick tests and serum IgE panels show limited diagnostic utility for identifying EoE-triggering foods. Patch testing and empiric elimination diets have greater clinical relevance in this condition.

Common scenarios

Presentation in children vs. adults

Children with EoE more commonly present with vomiting, feeding refusal, and failure to thrive. Adults more typically report solid-food dysphagia and acute food impaction requiring endoscopic removal. The American Gastroenterological Association (AGA) notes that food impaction is the presenting event in approximately 33% of adult EoE diagnoses.

The six-food elimination diet (SFED)

The empiric six-food elimination diet — removing milk, wheat, eggs, soy, tree nuts/peanuts, and seafood — has been studied extensively as both a diagnostic and therapeutic tool. Clinical trials have demonstrated histologic remission in approximately 70–80% of patients who eliminate all six food groups, with milk and wheat identified as the trigger foods in the majority of responders (Molina-Infante et al., Journal of Allergy and Clinical Immunology, 2014).

Overlap with atopic conditions

EoE occurs alongside atopic dermatitis, allergic rhinitis, and asthma at elevated rates. Studies in pediatric populations have found that 50–80% of EoE patients carry at least one concurrent atopic diagnosis. This pattern aligns with the progression described in allergy and the atopic march.

Decision boundaries

EoE vs. GERD

GERD can produce mild eosinophil infiltration in the distal esophagus (typically fewer than 15 eos/hpf), but does not produce the pan-esophageal eosinophilic infiltration seen in EoE. A PPI trial is sometimes used diagnostically — patients with PPI-responsive esophageal eosinophilia (PPI-REE) were previously classified separately, but the ACG 2022 guidelines collapsed PPI-REE into the EoE spectrum rather than treating it as a distinct entity.

EoE vs. other eosinophilic gastrointestinal disorders (EGIDs)

EoE is the most common EGID but must be distinguished from eosinophilic gastroenteritis and eosinophilic colitis, which involve eosinophil accumulation in the stomach, small intestine, or colon rather than exclusively the esophagus. Endoscopic biopsy mapping across multiple GI segments is required to establish anatomic specificity.

Diagnostic confirmation requirements

The diagnostic process for EoE requires:

  1. Symptomatic esophageal dysfunction (at least one clinical symptom)
  2. Esophageal biopsy demonstrating ≥15 eos/hpf
  3. Exclusion of secondary causes of esophageal eosinophilia (including GERD, Crohn's disease, celiac disease, and drug hypersensitivity reactions)
  4. Clinical–pathologic correlation by a gastroenterologist or allergist with EGID expertise

The comprehensive resource hub at allergyauthority.com covers the full range of allergic and immune-mediated conditions, including testing methods relevant to EoE evaluation such as the oral food challenge, which is used to confirm individual food triggers after dietary reintroduction.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)